Should I Buy ELUT? ELUT 2026 Analysis

Should You Buy Elutia Inc (ELUT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.990

1 Day change

4.77%

52 Week Range

3.460

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: no proprietary buy signals, no near-term catalyst flow, and fundamentals are still deteriorating.
Best stance is HOLD / wait for either (1) a clear technical breakout above ~$1.01–$1.11 with momentum, or (2) evidence of revenue stabilization; otherwise risk/reward is not compelling for an immediate entry.
The only strong positive is aggressive insider buying, which improves the longer-term setup but doesn’t create an immediate high-probability trade today.

Technical Analysis

Trend/Momentum: MACD histogram is slightly positive (0.00349) but contracting, implying weakening upside momentum rather than a fresh push higher.
RSI(6) ~52.7 (neutral): no overbought/oversold edge; price action lacks urgency.
Moving averages are converging: typically a consolidation/indecision regime, often preceding a bigger move, but direction is not confirmed.
Key levels: Pivot ~$1.013 is the near-term line in the sand; support at ~$0.911 then ~$0.849; resistance at ~$1.114 then ~$1.176.
Pattern-based odds (not a guarantee): modeled upside bias with ~2.99% next-day, 4.37% next-week, 9.43% next-month potential, but currently without a momentum trigger.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Insider activity is strongly positive: insiders are buying, with buying amount up ~1818% over the last month.
- Gross margin improved materially in the latest quarter (55.76%, +14.01% YoY), which can support a turnaround narrative if revenue stabilizes.
- If price reclaims/holds above the ~$1.01 pivot and clears ~$1.11, the chart would shift to a more actionable upside breakout setup.

Neutral/Negative Catalysts

- No news in the past week: limited event-driven catalysts to spark an immediate move.
- Growth and profitability trends are negative: revenue down YoY and losses widened significantly.
- MACD is positive but weakening (contracting), aligning with consolidation rather than a clean bullish impulse.
- Hedge funds are neutral with no significant trend over the last quarter (no strong institutional “push” indicated).

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: $3.323M, down -9.26% YoY (top-line contraction).
Net income: -$3.868M, down -462.51% YoY (loss widened sharply).
EPS: -$0.09, down -400% YoY.
Gross margin: 55.76%, up +14.01% YoY (a clear operational bright spot, but not yet translating into improving earnings due to scale/expenses).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided, so a clear Wall Street pro/con consensus view cannot be confirmed from this dataset.
Practical read-through from available inputs: pros = insider accumulation + improved gross margin; cons = shrinking revenue + sharply worse losses, which typically keeps professional sentiment cautious until a stabilization quarter appears.

2 Analyst Rating

Wall Street analysts forecast ELUT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELUT is 3.5 USD with a low forecast of 2 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.943

Low

Averages

3.5

High

Current: 0.943

Low

Averages

3.5

High

Cantor Fitzgerald

Overweight -> Overweight

downgrade

$7 -> $5

AI Analysis

2025-08-18

Reason

Cantor Fitzgerald

Price Target

$7 -> $5

AI Analysis

2025-08-18

downgrade

Overweight -> Overweight

Reason

Cantor Fitzgerald lowered the firm's price target on Elutia to $5 from $7 and keeps an Overweight rating on the shares.

Lake Street

Buy

downgrade

$10 -> $8

2025-05-09

Reason

Lake Street

Price Target

$10 -> $8

2025-05-09

downgrade

Buy

Reason

Lake Street lowered the firm's price target on Elutia to $8 from $10 and keeps a Buy rating on the shares. The firm thinks EluPro is "off to a remarkable start" and continues to believe a strategic exit materially above the company's current value is "the most likely outcome," though it reduced its price target on less value ascribed to SimpliDerm.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ELUT

Unlock Now

ELUT Should I Buy

ELUT Should I Buy

Should You Buy Elutia Inc (ELUT) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch